Wedbush Maintains Neutral on Voyager Therapeutics, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Laura Chico maintains a Neutral rating on Voyager Therapeutics (VYGR) and lowers the price target from $10 to $8.

May 14, 2024 | 12:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Wedbush analyst Laura Chico maintains a Neutral rating on Voyager Therapeutics and lowers the price target from $10 to $8.
The reduction in price target by a reputable analyst like Laura Chico could lead to a negative short-term sentiment among investors, potentially causing a decrease in VYGR's stock price. The maintenance of a Neutral rating indicates that the analyst does not see significant upside or downside from the current price level, but the lowering of the price target suggests a revision of the expected stock performance, which could influence investor perception and stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100